Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

DC-007D shows promise as novel thrombolytic in model of focal embolic stroke

Feb. 24, 2020

Neoral approved for acute stage Kawasaki disease in Japan

Feb. 24, 2020

BT-200 blocks VWF and platelet function in whole blood of patients with acute stroke

Feb. 21, 2020

European Commission approves Vyndaqel for ATTR-CM

Feb. 19, 2020

Anti-IL-1b platelet conjugate prevents sterile inflammation and adverse cardiac remodeling after AMI

Feb. 17, 2020

XyloCor begins first-in-human study of XC-001 gene therapy for refractory angina

Feb. 14, 2020

Endothelial cells have functional deficits in progeria

Feb. 13, 2020

CVie Therapeutics and UNIMIB divulge compounds for heart failure

Feb. 12, 2020

AskBio doses first patient in phase I study of NAN-101

Feb. 5, 2020

Agmatine is decreased in sepsis and may be a clinical biomarker and therapeutic agent

Feb. 5, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...